Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Zimpfer, D; Strueber, M; Aigner, P; Schmitto, JD; Fiane, AE; Larbalestier, R; Tsui, S; Jansz, P; Simon, A; Schueler, S; Moscato, F; Schima, H.
Evaluation of the HeartWare ventricular assist device Lavare cycle in a particle image velocimetry model and in clinical practice.
Eur J Cardiothorac Surg. 2016; 50(5):839-848 Doi: 10.1093/ejcts/ezw232
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Zimpfer Daniel
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
OBJECTIVES: Ventricular blood stasis is a concern for continuous flow mechanical support devices and might contribute to the formation of thromboembolic events. The HeartWare® Ventricular Assist System (HVAD®) is equipped with the Lavare™ cycle that is a periodic speed modulation feature designed to alter flow patterns within the left ventricle and reduce areas of potential blood stasis. Here, we report in vitro and clinical findings on the effects of the Lavare cycle. METHODS: The effect of pump speed changes on the intraventricular flow field was examined with an in vitro particle image velocimetry model. The clinical impact of the Lavare cycle was evaluated through a retrospective review of the ReVOLVE study which includes 248 patients implanted with the HVAD following Conformité Européenne Mark in nine centres in Europe and Australia. Baseline characteristics, adverse event profiles and Kaplan-Meier survival estimates were stratified by patients using/not using the Lavare cycle. RESULTS: Particle image velocimetry showed increased ventricular washout with an active Lavare cycle as measured by the fluid velocities and angular dispersion parameters. With the Lavare cycle on, there was also a 22% decrease in the stagnation index compared with when the Lavare cycle was off. In the ReVOLVE registry, patients with the Lavare cycle turned on (n = 215) were supported for 497 patient-years, whereas patients who did not use the speed modulation (n = 33) were supported for 39.3 patient-years. The Lavare cycle did not significantly affect patient survival as both groups had approximately an 80% survival after 1 year. Patients using the Lavare cycle had significantly fewer rates of stroke [0.06 vs 0.20 events per patient-year (EPPY), P = 0.0008], sepsis (0.03 vs 0.15 EPPY, P = 0.0003) and right heart failure (0.03 vs 0.18 EPPY, P < 0.0001) with no difference in the transplant or recovery rates among the two cohorts. CONCLUSIONS: The Lavare cycle effectively generates ventricular washout and the adverse event profiles of ReVOLVE patients with the Lavare cycle on were better than those with the Lavare cycle off. Larger studies are warranted to verify the positive effect of the Lavare cycle and to optimize speed modulation settings, so additional clinically relevant improvements can be realized.
Find related publications in this database (using NLM MeSH Indexing)
Adult - administration & dosage
Aged - administration & dosage
Australia - epidemiology
Blood Flow Velocity - physiology
Cardiomyopathy, Dilated - diagnostic imaging, physiopathology
Europe - epidemiology
Female - administration & dosage
Follow-Up Studies - administration & dosage
Heart Failure - mortality, physiopathology, surgery
Heart-Assist Devices - adverse effects
Hemorheology - physiology
Humans - administration & dosage
Kaplan-Meier Estimate - administration & dosage
Male - administration & dosage
Middle Aged - administration & dosage
Models, Cardiovascular - administration & dosage
Prosthesis Design - administration & dosage
Registries - administration & dosage
Retrospective Studies - administration & dosage
Sepsis - epidemiology, etiology, prevention & control
Stroke - epidemiology, etiology, prevention & control
Tomography, X-Ray Computed - administration & dosage
Treatment Outcome - administration & dosage
Ventricular Function - physiology

Find related publications in this database (Keywords)
Left ventricular assist device
Lavare cycle
Particle image velocimetry
HVAD
© Med Uni GrazImprint